YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Wall Street
Price Targets
Price Targets Summary
YiChang HEC ChangJiang Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 14.28 HKD with a low forecast of 14.14 HKD and a high forecast of 14.7 HKD.
Revenue
Forecast
Revenue Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 2 years is 19%.
Operating Income
Forecast
Operating Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 46%.
Net Income
Forecast
Net Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 2 years is 86%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's stock price target?
Price Target
14.28
HKD
According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 14.28 HKD with a low forecast of 14.14 HKD and a high forecast of 14.7 HKD.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
19%
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 2 years is 19%.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
46%
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 46%.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
86%
For the last 11 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 2 years is 86%.